Business Context and Reporting Period
Company: MEDICINOVA INC
Filing Type: Form 8-K (Current Report)
Date of Report: June 6, 2013
Reporting Period: Event date June 6, 2013
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses on a specific regulatory compliance event.
Material Changes and Events
- NASDAQ Delisting Notice: On June 6, 2013, the Company received notice from NASDAQ regarding a failure to comply with Listing Rule 5635(c).
- Cause of Non-Compliance: The violation stemmed from a May 9, 2013 issuance of common stock and warrants to Fountain Erika LLC at a discount to the market price. Fountain Erika LLC is an entity where Tatsuo Izumi, a board member, is a principal.
- Resolution: The Company regained compliance through a payment of $51,389 from Fountain Erika to the Company and an amendment to the Warrant to adjust the acquisition price to an "at the market" level.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The primary contingency addressed was the immediate risk of delisting, which was resolved within the reporting period.
Investor Verification Checklist
- Verify the current listing status of MEDICINOVA INC on NASDAQ.
- Confirm the terms of the amended Warrant issued to Fountain Erika LLC.
- Review the May 9, 2013 transaction details regarding the issuance of shares and warrants to related parties.
- Check for any subsequent filings regarding related party transactions or board member disclosures.